|
Volumn 5, Issue 4, 2004, Pages 433-434
|
New guidelines on the treatment of epilepsy with the new antiepileptic drugs: From the Epilepsy Foundation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ETIRACETAM;
GABAPENTIN;
LAMOTRIGINE;
OXCARBAZEPINE;
TIAGABINE;
TOPIRAMATE;
ZONISAMIDE;
COST CONTROL;
DRUG COST;
EDITORIAL;
EPILEPSY;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HOSPITAL CARE;
HUMAN;
MEDICAID;
MEDICAL DECISION MAKING;
MEDICARE;
NEUROSURGERY;
NON PROFIT ORGANIZATION;
PRACTICE GUIDELINE;
PRESCRIPTION;
SEIZURE;
SIDE EFFECT;
TREATMENT PLANNING;
VAGUS NERVE STIMULATION;
ANTICONVULSANTS;
EPILEPSY;
HUMANS;
PRACTICE GUIDELINES;
|
EID: 4043160039
PISSN: 15255050
EISSN: None
Source Type: Journal
DOI: 10.1016/j.yebeh.2004.05.004 Document Type: Editorial |
Times cited : (4)
|
References (0)
|